Cardiomyoplasty benefits in experimental myocardial dysfunction.

Area of Science:

• Cardiovascular Surgery
• Regenerative Medicine
• Cardiac Physiology

Background:

• Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
• Current treatments for irreversible cardiomyopathy have limitations.
• Cardiomyoplasty, using latissimus dorsi muscle flaps, has shown potential benefits.

Purpose of the Study:

• To evaluate the effectiveness of stimulated preconditioned latissimus dorsi muscle flaps in restoring ventricular contractility.
• To assess hemodynamic and echocardiographic changes after cardiomyoplasty in a canine model of heart failure.

Main Methods:

• Induced myocardial dysfunction in six mongrel dogs using beta-blockers and volume loading.
• Surgical implantation of latissimus dorsi muscle flaps around the heart.
• Hemodynamic and 2D echocardiographic evaluations pre- and post-procedure and after heart failure induction.
• Synchronous pulse train electrical stimulation of the muscle flap.

Main Results:

• Cardiac output increased significantly (1.46 to 2.01 L/min, p<0.01).
• Pulmonary wedge pressure and left ventricular end-diastolic pressure decreased significantly (p<0.01 and p<0.04, respectively).
• Left ventricular ejection fraction increased from 39.3% to 59.6% (p<0.01), and segmental wall shortening improved (p<0.01).

Conclusions:

• Stimulated cardiomyoplasty can restore ventricular contractility in heart failure.
• This technique may be a viable treatment for irreversible cardiomyopathy, even with significant cardiac enlargement.
• Partial wrapping of the muscle flap around the heart also yielded positive results.